Document is current
Any future updates will be listed below
-
Authors
Vetsch, Thomas https://orcid.org/0000-0002-4231-7837
Dueblin, Simone Wen-Shi https://orcid.org/0009-0009-4684-6304
Eser, Prisca https://orcid.org/0000-0001-9734-0682
Beilstein, Christian M. https://orcid.org/0000-0002-1366-2949
Wuethrich, Patrick Y. https://orcid.org/0000-0003-3704-6785
Wilhelm, Matthias https://orcid.org/0000-0003-4541-3995
Engel, Dominque https://orcid.org/0000-0003-0544-7170
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (33IC30_201298)
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 17 June 2025
First Online: 4 July 2025
Declarations
:
: All patients were asked for their informed consent to use their data for the study. Non-consent did not impact their treatment since all patients received standard of care. The PREHABIL trial study has been accepted by the responsible Research Ethics Committee (REC) of the Canton of Bern, Switzerland (Kantonale Ethikkommission Bern 2020-01690).
: Not applicable.
: The authors declare no competing interests.
